Huamao Wang
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Co-authors
- Zonghai LiHua JiangZhaojun YangBizhi ShiHuiping GaoHongyang WangHonghong ZhangDonghua Shi
- Journals
- Journal of Clinical Oncology (6 papers)Technological Forecasting and Social Change (3 papers)European Journal of Operational Research (3 papers)Blood (3 papers)Cancer Letters (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Huamao Wang
51 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 109
- Oncology 876
- Immunology 452
- Hepatology 155
- Finance 113
- Cancer Research 139
Countries citing papers authored by Huamao Wang
This map shows the geographic impact of Huamao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huamao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huamao Wang more than expected).
Fields of papers citing papers by Huamao Wang
This network shows the impact of papers produced by Huamao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huamao Wang. The network helps show where Huamao Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Huamao Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 46 | |
| 3 | 2022 | 15 | |
| 4 | 2021 | 17 | |
| 5 | 2020 | 254 | |
| 6 | 2019 | 118 | |
| 7 | 2018 | 38 | |
| 8 | 2018 | 5 | |
| 9 | 2016 | 22 | |
| 10 | 2016 | 82 | |
| 11 | 2014 | 39 | |
| 12 | 2013 | 20 | |
| 13 | 2013 | 15 | |
| 14 | 2012 | 12 | |
| 15 | 2011 | 10 | |
| 16 | 2010 | 17 | |
| 17 | 2009 | 37 | |
| 18 | Preparation and identification of a 9B9 monoclonal antibody specifically targeting EGFRvIII/EGFR. | 2009 | 1 |
| 19 | 2009 | 22 | |
| 20 | 2004 | 8 |
About Huamao Wang
Huamao Wang is a scholar working on Finance, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Accounting, having authored 51 papers that have together received 1.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (16 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Stochastic processes and financial applications (10 papers), Financial Markets and Investment Strategies (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Economic theories and models (5 papers). The work is most often cited by research in Oncology (876 citations), Immunology (452 citations), Hepatology (155 citations), Finance (113 citations) and Cancer Research (139 citations). Huamao Wang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Zonghai Li, Hua Jiang, Zhaojun Yang, Bizhi Shi, Huiping Gao, Hongyang Wang, Honghong Zhang, Donghua Shi, Xingxing Qi and Jiachang Chi. Their work appears in journals such as Journal of Clinical Oncology, Technological Forecasting and Social Change, European Journal of Operational Research, Blood and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.